Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
02/2006
02/09/2006US20060029829 Organometallic complexes as phosphorescent emitters in organic LEDS
02/09/2006CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
02/09/2006CA2576073A1 Novel piperidine derivative for the treatment of depression
02/09/2006CA2575329A1 Indole, indazole or indoline derivatives
02/09/2006CA2574966A1 Isoindoline compounds and methods of their use
02/09/2006CA2571789A1 Indoles having anti-diabetic activity
02/08/2006EP1623985A2 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventative agents
02/08/2006EP1623976A1 Method for separation of optically active dihydroxy- heptenoic acid esters
02/08/2006EP1623970A1 Arylamine compound and organic electroluminescence device containing the same
02/08/2006EP1623712A2 Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues
02/08/2006EP1623223A2 Fluorescently tagged ligands
02/08/2006EP1622895A2 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions comprising the same and use thereof
02/08/2006EP1622886A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
02/08/2006EP1622865A2 Novel bioisosteres of actinonin
02/08/2006EP1358162B1 Dihydroindole and tetrahydroquinoline derivatives
02/08/2006EP1318978B1 N-acylsulfonamide apoptosis promoters
02/08/2006CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives
02/08/2006CN1732158A Indazole derivatives as CRF antagonists
02/08/2006CN1732145A Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
02/08/2006CN1730481A 5-aza-indole preparation method
02/08/2006CN1240700C Aromatic heterocyclic carboxylic acid derivative, preparing method and application in medicine
02/08/2006CN1240681C Nitrile derivatives as cathepsin K inhibitors
02/08/2006CN1240680C 1,4-pentadiene-3-ketone compound containing halogenoindyl, and method for preparing same and medicinal use thereof
02/08/2006CN1240679C 2- and 2,5-substituted phenylketoenols
02/08/2006CN1240677C Monofluoroalkyl derivatives
02/08/2006CN1240388C Selective estrogen receptor modulator in combination with dehydroepiandrosterone or its derivative
02/08/2006CN1240380C Phase transfer catalyzed glycosidation of an indolocarbazole
02/07/2006USRE38970 Indolyl or indolinyl derivatives and medicinal use thereof as ACAT or lipid peroxidation inhibitors
02/07/2006US6995284 Synthesis of selective androgen receptor modulators
02/07/2006US6995274 Cyanine dyes
02/07/2006US6995269 Guanidinobenzamides
02/07/2006US6995184 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors
02/07/2006US6995183 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
02/07/2006US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders
02/07/2006US6995180 for the treatment of diabetes, hyperglycemia, hypoglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis, eating disorders, and nervous system disorders
02/07/2006US6995176 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
02/02/2006WO2006012310A2 Carbazole derivatives for treating polycystic kidney disease
02/02/2006WO2006012227A2 Amido compounds and their use as pharmaceuticals
02/02/2006WO2006012162A2 Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom
02/02/2006WO2006011469A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
02/02/2006WO2006011035A1 Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them
02/02/2006WO2006010965A1 Indole-2 -carboxamidine derivatives as nmda receptor antagonists
02/02/2006WO2005032594A3 Alkylators linked to polyamides as dna binding agents
02/02/2006US20060025601 Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators
02/02/2006US20060025596 Method for deuteration or tritiation of heterocyclic ring
02/02/2006US20060025594 Small molecule entry inhibitors
02/02/2006US20060025587 Process for the preparation of alpha-aminosubstituted carboxylic acid amides
02/02/2006US20060025467 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors
02/02/2006US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels
02/02/2006US20060025413 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
02/02/2006US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
02/02/2006US20060025402 Benzimidazolidinone derivatives as muscarinic agents
02/02/2006US20060024775 Substrates for o6-alkylguanina-dna alkyltransferase
02/02/2006DE112004000350T5 Organische Verbindung und organisches elektrolumineszierendes Element Organic compound and an organic electroluminescent element
02/02/2006CA2574155A1 Indole-2 -carboxamidine derivatives as nmda receptor antagonists
02/02/2006CA2573777A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
02/02/2006CA2570694A1 Amido compounds and their use as pharmaceuticals
02/01/2006EP1620434A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands
02/01/2006EP1620422A2 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
02/01/2006EP1620420A2 Substituted carboxylic acids
02/01/2006EP1620399A1 Indolone-acetamide derivatives, processes for preparing them and their uses
02/01/2006EP1620398A1 Process for the preparation of indole derivatives by enzymatic acylation
02/01/2006EP1620397A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
02/01/2006EP1620102A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
02/01/2006EP1620088A2 Indole acetic acid derivatives and their use as pharmaceutical agents
02/01/2006EP1620087A1 Azabicyclo derivatives as muscarinic receptor antagonists
02/01/2006EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
02/01/2006EP1104289B1 New oral formulation for 5-ht4 agonists or antagonists
02/01/2006EP1080078B1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
02/01/2006CN1729197A Tetracyclic 3-substituted indoles having serotonin receptor affinity
02/01/2006CN1729190A Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
02/01/2006CN1729181A Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
02/01/2006CN1729174A Synthesis of amines and intermediates for the synthesis thereof
02/01/2006CN1729173A N-(indolethyl-) cacloamine compounds
02/01/2006CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/01/2006CN1727339A Tricyclic compounds, their production and use
02/01/2006CN1727332A Compound in category of aryl methylamino dithio formic ether, preparation method and application
02/01/2006CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha
02/01/2006CN1239483C Preparation method of medicine intermediate gramine
02/01/2006CN1239482C Positive modulators for nicotinic receptor agonists
01/2006
01/31/2006US6992101 indole and thieno (2,3-B)pyrrole compounds with 1,1-dioxo tetrahydro thiophene or pyran ring; treating diabetes, insulin resistance, diabetic neuropathy, diabetic nephropathy, hypertension, hyperinsulinemia, hyperlipidemia, ischemia
01/31/2006US6992100 sPLA2 inhibitors
01/26/2006WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
01/26/2006WO2006010082A1 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
01/26/2006WO2006008250A2 Oxime derivatives and the use therof as latent acids
01/26/2006WO2006007843A1 2-(1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence
01/26/2006US20060020136 Phenylcarbazole compounds and organic electroluminescence devices using the same
01/26/2006US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents
01/26/2006US20060020003 Biphenyloxy-acids
01/26/2006US20060020002 (3a alpha ,4 alpha ,7 alpha ,7a alpha )-Octahydro-3-hydroxy-2-[4-nitro-3-(trifluoromethyl)phenyl]-4,7-methano-1H-isoindol-1-one (2); steroid mimic; competitive inhibitors of intercellular ligand binding reactions involving CAMs and Leukointegrins; anticarcinogenic agent; autoimmune diseases
01/26/2006US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists
01/26/2006US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives
01/26/2006DE102004030900A1 Herstellung teilchenförmiger Peroxycarbonsäurezusammensetzungen Preparation of particulate Peroxycarbonsäurezusammensetzungen
01/26/2006CA2574475A1 Indolone derivatives, processes for preparing them and their uses
01/26/2006CA2574237A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
01/26/2006CA2574054A1 Oxime derivatives and the use therof as latent acids
01/26/2006CA2573210A1 Viral polymerase inhibitors
01/26/2006CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
01/26/2006CA2572047A1 Octahydropyrrolo[2,3,c]pyridine derivatives and pharmaceutical use thereof
01/25/2006EP1619230A1 Red light emitting compounds for organic electroluminescent devices and organic electroluminescent devices using them